UMediC Group Berhad (KLSE:UMC)

Market Cap	115.91M -22.5%
Revenue (ttm)	51.50M +0.6%
Net Income	8.18M -2.2%
EPS	0.02 -2.2%
Shares Out	373.91M
PE Ratio	14.19
Forward PE	15.50
Dividend	0.01 (1.94%)
Ex-Dividend Date	Jan 29, 2026

Volume	126,200
Open	0.3200
Previous Close	0.3200
Day's Range	0.3100 - 0.3200
52-Week Range	0.2800 - 0.4750
Beta	0.20
Analysts	Hold
Price Target	0.31 (0.0%)
Earnings Date	Jun 5, 2026

About UMediC Group Berhad

UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It also provides HYDROX prefilled humidifiers and nebulizers; AIRDROX inhaler spacers; FLEXIDROX water for inhalation bag; and hospital furnit...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2021
• Employees: 166
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: UMC

Financial Performance

In fiscal year 2025, UMediC Group Berhad's revenue was 48.56 million, a decrease of -11.01% compared to the previous year's 54.57 million. Earnings were 8.13 million, a decrease of -9.53%.

Analyst Summary

According to 2 analysts, the average rating for UMC stock is "Hold." The 12-month stock price target is RM 0.31, which is no change of 0.00% from the latest price.

Price Target

RM 0.31

Analyst Consensus: Hold